Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Bratton

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Thorax|November 1, 2012
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trialSonya Elizabeth Craig, Malcolm Kohler, Debby Nicoll, et al.
Statistics in Medicine|July 7, 2015
Comments on 'A modest proposal for dropping poor arms in clinical trials' by Proschan and DoddDaniel J Bratton, Babak Choodari-Oskooei, Patrick P J Phillips, et al.
The Clinical Respiratory Journal|January 26, 2022
Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthmaFrank C Albers, Daniel J Bratton, Necdet B Gunsoy, et al.
ERJ Open Research|July 30, 2024
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placeboImran Howell, Daniel J Bratton, Gareth Hynes, et al.
Respiratory Research|August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCAFrank C Albers, Alberto Papi, Camille Taillé, et al.
Clinical Trials (London, England)|February 18, 2020
Adding new experimental arms to randomised clinical trials: Impact on error ratesBabak Choodari-Oskooei, Daniel J Bratton, Melissa R Gannon, et al.
Journal of Thoracic Disease|September 21, 2018
Effect of continuous positive airway pressure therapy on circadian patterns of cardiac repolarization in patients with obstructive sleep apnoea: data from a randomized trialChristian Schlatzer, Daniel J Bratton, Esther I Schwarz, et al.
Allergy|September 15, 2019
Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab useFrank C Albers, Soichiro Hozawa, Daniel J Bratton, et al.
The Journal of Allergy and Clinical Immunology|September 12, 2018
Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparisonWilliam Busse, Geoffrey Chupp, Hiroyuki Nagase, et al.
Plos One|April 13, 2016
Simulated Obstructive Sleep Apnea Increases P-Wave Duration and P-Wave DispersionThomas Gaisl, Annette M Wons, Valentina Rossi, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Thorax|November 1, 2012
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trialSonya Elizabeth Craig, Malcolm Kohler, Debby Nicoll, et al.
Statistics in Medicine|July 7, 2015
Comments on 'A modest proposal for dropping poor arms in clinical trials' by Proschan and DoddDaniel J Bratton, Babak Choodari-Oskooei, Patrick P J Phillips, et al.
The Clinical Respiratory Journal|January 26, 2022
Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthmaFrank C Albers, Daniel J Bratton, Necdet B Gunsoy, et al.
ERJ Open Research|July 30, 2024
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placeboImran Howell, Daniel J Bratton, Gareth Hynes, et al.
Respiratory Research|August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCAFrank C Albers, Alberto Papi, Camille Taillé, et al.
Clinical Trials (London, England)|February 18, 2020
Adding new experimental arms to randomised clinical trials: Impact on error ratesBabak Choodari-Oskooei, Daniel J Bratton, Melissa R Gannon, et al.
Journal of Thoracic Disease|September 21, 2018
Effect of continuous positive airway pressure therapy on circadian patterns of cardiac repolarization in patients with obstructive sleep apnoea: data from a randomized trialChristian Schlatzer, Daniel J Bratton, Esther I Schwarz, et al.
Allergy|September 15, 2019
Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab useFrank C Albers, Soichiro Hozawa, Daniel J Bratton, et al.
The Journal of Allergy and Clinical Immunology|September 12, 2018
Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparisonWilliam Busse, Geoffrey Chupp, Hiroyuki Nagase, et al.
Plos One|April 13, 2016
Simulated Obstructive Sleep Apnea Increases P-Wave Duration and P-Wave DispersionThomas Gaisl, Annette M Wons, Valentina Rossi, et al.
Pageof 5